The first patient has been dosed in a Phase 1/2 clinical study of VTx-002, an experimental therapy for amyotrophic lateral sclerosis.
PHILADELPHIA, PA — Aro Biotherapeutics reported interim data from a Phase 1b study of ABX1100, an investigational therapy for late-onset Pompe disease, showing the drug was generally well tolerated ...
In cellular and animal models of neuroblastoma, small cell lung cancer and colon cancer, this strategy reduces tumours, ...
A new study has confirmed that male and female lungs are "wired differently" at the molecular level, providing further evidence supporting sex-inclusive respiratory disease research and treatment. The ...
An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" ...
Severe accidents in nuclear reactors, though low-probability events, pose significant risks to human safety, the environment, and public trust in nuclear ...
In Phase II data released this week, people taking a monthly dose of PF’3944 continued to lose more weight than those on a ...
An experimental pain medicine met the primary goal of a late-stage clinical trial, the drug’s maker said Tuesday, setting the stage for it to seek approval from the US Food and Drug Administration ...